Product Information
Registration Status: ActiveSIN14824P
BICAMED 50 BICALUTAMIDE TABLET 50MG is approved to be sold in Singapore with effective from 2015-04-08. It is marketed by MEDICELL PHARMACEUTICAL (S) PTE LTD, with the registration number of SIN14824P.
This product contains Bicalutamide 50mg in the form of TABLET. It is approved for ORAL use.
This product is manufactured by Hetero Labs LTD in INDIA.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Description
Bicalutamide is an oral non-steroidal anti-androgen for prostate cancer. It is a racemic mixture consisting of equal proportions of enantiomers (R)-bicalutamide and (S)-bicalutamide. Bicalutamide binds to the androgen receptor.
Indication
For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer.
Mechanism of Action
Bicalutamide competes with androgen for the binding of androgen receptors, consequently blocking the action of androgens of adrenal and testicular origin which stimulate the growth of normal and malignant prostatic tissue.
Pharmacokinetics
- Absorption
- Bicalutamide is well-absorbed following oral administration, although the absolute bioavailability is unknown.
- Distribution
- Metabolism
- Bicalutamide undergoes stereo specific metabolism. The S (inactive) isomer is metabolized primarily by glucuronidation. The R (active) isomer also undergoes glucuronidation but is predominantly oxidized to an inactive metabolite followed by glucuronidation.
- Elimination
Clearance
* Apparent oral cl=0.32 L/h [Normal Males]
Active Ingredient/Synonyms
Bicalutamida | Bicalutamide | Bicalutamidum | Bicalutamide |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.